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Abstract
Background: Increased prevalence of atherosclerotic cardiovascular disease in HIV-infected patients has been observed. The
cause of this accelerated atherosclerosis is a matter of controversy. As clinical studies are complicated by a multiplicity of
risk-factors and a low incidence of hard endpoints, studies in animal models could be attractive alternatives.
Methodology/Principal Findings: We evaluated gene expression of lectin-like oxidized-low-density-lipoprotein receptor-1
(LOX-1), vascular cell adhesion molecule-1 (VCAM-1), and intercellular adhesion molecule-1 (ICAM-1) in HIV-1 transgenic
(HIV-1Tg) rats; these genes are all thought to play important roles in early atherogenesis. Furthermore, the plasma level of
sICAM-1 was measured. We found that gene expressions of LOX-1 and VCAM-1 were higher in the aortic arch of HIV-1Tg rats
compared to controls. Also, the level of sICAM-1 was elevated in the HIV-1Tg rats compared to controls, but the ICAM-1
gene expression profile did not show any differences between the groups.
Conclusions/Significance: HIV-1Tg rats have gene expression patterns indicating endothelial dysfunction and accelerated
atherosclerosis in aorta, suggesting that HIV-infection per se may cause atherosclerosis. This transgenic rat model may be a
very promising model for further studies of the pathophysiology behind HIV-associated cardiovascular disease.
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Introduction
The morbidity and mortality among patients with human
immunodeficiency virus (HIV) infection has declined dramatically
since the introduction of antiretroviral therapy (ART). Concom-
itantly, increased rates of atherosclerotic cardiovascular disease in
HIV-infected patients have been observed. However, the cause of
accelerated atherosclerosis behind most cardiovascular diseases,
developed by HIV-patients, is still a matter of controversy. Three
possibilities have been suggested: the infection itself, the treatment
used or the dyslipidemia often seen in HIV-patients [1,2]. The
clinical studies are limited by the fact that the patients are
influenced not by one but many factors, including different
cardiovascular risk-factors, e.g. smoking. As it is not possible to
totally isolate the different causes in clinical experiments, an
animal model represents an attractive alternative to investigate in
detail the origin of accelerated atherosclerosis associated with
HIV-infection per se.
A transgenic rat model of HIV was constructed in 2001 (the
HIV-1Tg rat) based on a Sprague-Dawley x Fisher 344/NHsd F1
background [3]. The HIV-1Tg rat contains a gag-pol-deleted HIV-
1 provirus regulated by a viral promoter. Several experiments have
shown this rat model to display clinical manifestations resembling
the manifestations seen in HIV-patients. These manifestations
include wasting, skin lesions, cataract, neurological signs, and
respiratory difficulty. Furthermore, the cardiac pathology seen in
the HIV-1Tg rat resembles the pathology seen in HIV-patients
[3–6]. To our knowledge, development of atherosclerosis has not
previously been investigated in the HIV-1Tg rat or any other HIV
animal model.
The first stage of atherosclerosis is considered to be endothelial
dysfunction [7,8]. As we want to investigate atherosclerosis in
HIV-1Tg rats, although rats do not normally have this disease [9],
we have chosen to focus on targets that are characteristic of the
earliest stage of atherosclerosis. The three targets used in this study
are: lectin-like oxidized-low-density-lipoprotein receptor-1 (LOX-
1), vascular cell adhesion molecule-1 (VCAM-1), and intercellular
adhesion molecule-1 (ICAM-1).
Oxidized low-density lipoprotein (oxLDL) is important in the
initiation and development of atherosclerosis. The primary
endothelial receptor of oxLDL, LOX-1, is responsible for binding,
internalization, and degradation of oxLDL in endothelial cells.
Both in vitro and in vivo experiments have shown the receptor to be
important in the initiation of atherosclerosis and to be up-
regulated by pro-atherogenic factors, e.g. shear stress, tumor
necrosis factor (TNF)-a, and oxLDL itself [10,11].
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of atherosclerosis as they are vital to leukocyte attachment, rolling,
and trans-endothelial migration. VCAM-1 is primarily an
inducible molecule, whereas ICAM-1 is also constitutively
expressed on resting endothelial cells. They are both up-regulated
by pro-atherogenic factors. VCAM-1 has, based on experiments
with knockout mice, been recognized as the crucial adhesion
molecule in the initiation of atherosclerosis [12,13]. A high level of
soluble ICAM-1 (sICAM-1) in plasma has been linked to increased
risk of cardiovascular events, as well as to cancer and autoimmune
diseases [14].
The aim of the present study was to look at regional gene
expression of LOX-1, VCAM-1, and ICAM-1 in the aorta of
HIV-1Tg rats to identify possible signs of accelerated atherogen-
esis caused by HIV. Furthermore, the plasma level of sICAM-1
was measured.
Results
Gene Expression
Gene expression of LOX-1 (Fig. 1A) was significantly up-
regulated in the aortic arch of HIV-1Tg rats compared to control
rats (3.4-fold, p=0.041). A tendency to LOX-1 up-regulation in
the thoracic (p=0.13) and abdominal aorta (p=0.14) compared to
the control rats was also present, although non-significant.
Gene expression of VCAM-1 (Fig. 1B) was significantly up-
regulated in the aortic arch of HIV-1Tg rats compared to the
control rats (1.5-fold, p=0.044). No differences were found in the
Figure 1. Gene expression relative to the calibrator (RQC) expressed as mean 6SEM of n=8–12. (A) LOX-1: *p,0.05 aortic arch, HIV-1Tg
vs. control rats;
Dp,0.05 control rats, aortic arch vs. abdominal aorta. (B) VCAM-1: *p,0.05 aortic arch, HIV-1Tg vs. control rats;
Dp,0.05 HIV-1Tg rats,
aortic arch vs. abdominal aorta. (C) ICAM-1:
DDDp,0.001 control rats, aortic arch vs. abdominal aorta.
doi:10.1371/journal.pone.0008170.g001
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In HIV-1Tg rats the gene expression level for VCAM-1 was
higher in the aortic arch compared to the abdominal aorta (1.9-
fold, p=0.011).
There were no significant differences in ICAM-1 gene
expression between HIV-1Tg and control rats (Fig. 1C).
Plasma Level of sICAM-1
The plasma level of sICAM-1 is shown in Fig. 2.
sICAM-1 was significantly increased in the HIV-1Tg rats
compared to the control rats (1.7-fold, p=0.009). The range of
sICAM-1 was 4.3–17.2 ng/mL.
Discussion
Here we show for the first time that gene expression of LOX-1
and VCAM-1 are up-regulated in the aortic arch of HIV-1Tg rats
compared to control rats. In contrast, the gene expression of
ICAM-1 was not signficantly up-regulated. Although the HIV-
infected rats did not display overt atherosclerosis, the up-
regulation of LOX-1 and VCAM-1 indicates early atherogenesis
in these rats. Therefore, even though overt atherosclerosis is
normally not seen in rats [9], our study indicates that early, pre-
atherosclerosis can still be studied in HIV-1Tg rats. Accordingly,
the HIV-1Tg rat-model seems suitable for further studies of
development of accelerated atherosclerosis in HIV.
The up-regulation of LOX-1 and VCAM-1, but not ICAM-1 is
in line with our previous study of pre-atherosclerotic apoE
2/2
mice [15]. According to that study, ICAM-1 did not seem to play a
role in atherogenesis as early as LOX-1 and VCAM-1. Another
study using immunohistochemistry found VCAM-1 to be up-
regulated in 20 weeks old apoE
2/2 mice compared to control
mice. The up-regulation of VCAM-1 was further increased by
high-fat diet, whereas ICAM-1 was unaffected by both apoE-
deficiency and high-fat diet [16]. These studies support that our
findings in the present study are signs of early atherosclerosis.
The significant up-regulation of LOX-1 and VCAM-1 in the
aortic arch but not in the other areas of the aorta is not
unexpected. It has long been known that specific patterns of shear
stress influence gene expression in the vessel wall. The initial
observation was that atherosclerosis develops in a non-random
pattern [17] . A study of aortas from normal adult pigs showed
higher expression of pro-inflammation associated genes in the
aortic arch than in the thoracic aorta. They concluded that regions
with low shear stress (aortic arch) were more atherosclerosis-
susceptible than regions with laminar flow and high shear stress
(thoracic aorta) [18]. Numerous studies of cell cultures using
different flow apparatuses have demonstrated the association
between the hemodynamics of vessels and the expression of pro-
atherosclerotic genes. A study from 2002 using human aortic
endothelial cells showed VCAM-1 to be up-regulated by disturbed
flow which is characteristic of the aortic arch. The expression of
ICAM-1 was only transiently upregulated [19]. Based on both in
vitro and in vivo experiments, the overall conclusion is that low,
disturbed, or oscillating flow patterns promote a pro-inflammatory
phenotype that paves the way for atherosclerosis [20,21]. In
accordance with this, we found indications of HIV-induced
accelerated atherosclerosis in the aortic arch, where low and
oscillating flow is present.
We found that sICAM-1 was significantly higher in HIV-1Tg
rats compared to control rats. In accordance with our results,
clinical studies have shown that sICAM-1 is up-regulated in HIV-
patients compared to non-infected individuals [22,23]. The origin
of sICAM-1 is so far unknown [14]. The higher plasma level of
sICAM-1 without upregulation of the gene expression of ICAM-1
in the aorta indicates that vessels may not be the major source of
sICAM-1.
The relevance of specific HIV-proteins to the development of
atherosclerosis has so far not been fully revealed. Until now the
research calls attention to the HIV proteins Tat, gp120 and Nef as
possible mediators of endothelial dysfunction [24]. As these
proteins are expressed in all cells of the HIV-1Tg rat, this study
cannot disclose their relevance for the disease. However, it could
be an interesting future area of investigation to study the impact of
these proteins on atherogenesis in an animal model.
In conclusion, HIV-1Tg rats have gene expression patterns
indicating accelerated atherosclerosis in the aortic arch. This
indicates that HIV-infection per se seems to cause atherosclerosis.
The HIV-1Tg rat may be a promising model for further studies of
the pathophysiology behind HIV-related cardiovascular disease,
e.g. time-course of the atherogenesis and relative importance of
HIV-infection and anti-retroviral treatment. Furthermore, it will
be interesting to study how different risk-factors, e.g. high-fat diet,
influence the HIV-related atherogenesis.
Materials and Methods
Experimental Model
Animal care and all experimental procedures were performed
under the approval of the Danish Animal Welfare Council.
Eight male HIV-1 transgenic rats and 12 parental wild-type
inbred F344/NHsd control background strain rats were purchased
from Harlan (IN, USA).
The rats were housed under humidity-, temperature-, and light
cycle-controlled conditions, and had free access to standard rat
diet and water throughout the course of experiments.
Sample Handling
At the age of 10–12 months, the animals were anesthetized with
3% sevoflurane (Abbott Scandinavia AB, Sweden) mixed with
35% O2 in N2 by breathing and subsequently decapitated. Blood
Figure 2. The plasma level of sICAM-1 expressed as mean
6SEM of n=8–12. **p,0.01 HIV-1Tg vs. control rats.
doi:10.1371/journal.pone.0008170.g002
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and stored at 220uC.
The aorta was removed and divided into the aortic arch, the
thoracic aorta, and the abdominal aorta. The samples were placed
in RNAlaterH (Ambion (Europe) Limited, UK) and stored at 4uC.
The following day RNAlaterH was removed and the samples were
stored at 280uC.
RNA Extraction and Reverse Transcription
Total RNA was isolated with TRI ReagentH (Molecular
Research Center Inc., OH, USA), and 0.3 mg total RNA was
reversed transcribed using the AffinityScript
TM QPCR cDNA
Synthesis Kit from (Stratagene, CA, USA, cat.# 600559). Samples
were cooled down and stored at 220uC.
Real-Time qPCR
Gene expression was quantified on the Mx3000PH and
Mx3005P
TM real-time PCR systems from Stratagene. LOX-1
was quantified in a duplex with glyceraldehydes-3-phosphate
dehydrogenase (GAPDH), while VCAM-1, ICAM-1, and
GAPDH were quantified in a triplex. The BrilliantH QPCR Core
Reagent Kit (Stratagene, cat.# 600530) was used. Optimization of
assays resulted in a 50% and 100% increase of dNTP and Taq
polymerase for the duplex and triplex, respectively. An MgCl2
concentration of 5.5 mM was found to be optimal for all
experiments. The thermal profile used was: 10 min of denatur-
ation at 95uC followed by 45 cycles with denaturation for 30 s at
95uC and annealing/elongation at 60uC for 1 min.
Relative quantification by the comparative method (2
2DDCt)
[25] was used. A calibrator consisting of a pool of cDNA from all
control rats was used. Furthermore, the measurements were
corrected for the efficiency of the PCR reaction, calculated from 5-
fold dilution curves, thereby replacing 2 in the formula with (1+E).
The optimal housekeeping gene for the study was selected from
a panel of twelve common endogenous control genes (pre-
fabricated panel from PrimerDesign, UK). All 12 genes were
tested by qPCR in both HIVTg and control rats. NormFinder
[26] was used to find the optimal housekeeping gene. GAPDH was
found to be the most representative housekeeping gene.
Primers and TaqMan dual-labeled probes for the three genes of
interest LOX-1 (NM_133306), VCAM-1 (NM_012889), and
ICAM-1 (NM_012967) along with the housekeeping gene
GAPDH (NM_017008) were designed using Beacon Designer
(PREMIER Biosoft, CA, USA). Primers and probes are shown
Table 1. All primers and probes were purchased from Eurofins
MWG (Ebergsberg, Germany).
For each gene, the optimal primer and probe concentration was
established (Table 2). All samples were run as triplicates using 1 mL
of cDNA.
Plasma Measurements
All plasma samples were measured using a bead-based sandwich
immunoassay technique [27,28]. A commercially available kit
(cat.# RCVD2-89K-01, LINCO Research, MO, USA) was used.
The samples were analyzed on the Luminex
TM LX100 with
STarStation 2.0 software (Millipore Corporation, MA, USA).
Statistical Analysis
All data were tested by means of Kolmogorov-Smirnov and
found to be normal distributed. Comparisons between the
different rat groups were performed by Student’s t-test for
independent samples and between regions of aorta with a paired
t-test. Bonferroni corrections for planned comparisons were
performed when more than two groups were compared. P,0.05
was considered significant.
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Table 2. Optimal filter setting, primer- and probe-concentration for the genes investigated.
Name Forward primer-concentration, nM Reverse primer-concentration, nM Probe-concentration, nM Filter settings
LOX-1 300 300 400 FAM 64
VCAM-1 600 300 250 CY5 62
ICAM-1 300 300 300 FAM 64
GAPDH 300 300 250 HEX 62
doi:10.1371/journal.pone.0008170.t002
Table 1. Primers and probes.
Name Forward primer (59–39) Reverse primer (59–39)5 9 fluoro-phore Probe (59–39)3 9 quen-cher
Amplicon
length (bp)
LOX-1 ttgcatactttgtagacagtctctc ctgagtttcatccattttggtcatg FAM ttgaccctgccatgccatgctatga BHQ-1 88
VCAM-1 tttgcaagaaaagccaacatgaaag tctccaacagttcagacgttagc CY5 ctgtgcctccaccagactgtacgat BHQ-2 88
ICAM-1 agatcatacgggtttgggcttc tatgactcgtgaaagaaatcagctc FAM ccacaggtcagggtgctttcctcaa BHQ-1 75
GAPDH ccgtgttcctacccccaatg cttcaccaccttcttgatgtcatc HEX ctccaggcggcatgtcagatccac BHQ-1 91
doi:10.1371/journal.pone.0008170.t001
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